TY - JOUR
AR - COR-2019-6-103
TI - Graviola in Metastatic Ovarian Cancer: A Case Report of Sustained Disease Stability
AU - Philip, Beale
AU - Sarah, Syed
AU - Thi Thuy, Duong Pham
JO - Clinical Oncology and Research
PY - 2019
DA - Fri 29, Nov 2019
SN - 2613-4942
DO - http://dx.doi.org/10.31487/j.COR.2019.06.03
UR - https://www.sciencerepository.org/graviola-in-metastatic-ovarian-cancer-a-case-report-of-sustained-disease-stability_COR-2019-6-103 
KW - Metastatic ovarian cancer, complementary medicine, graviola, Annona muricata
AB - Treatments for metastatic ovarian cancer to date have been limited by advanced stages at diagnosis,
drug toxicity and resistance. Cancer patients are also increasingly looking towards complementary
and alternative therapies. Graviola (Annona muricata) has traditionally been used in many conditions
including cancer, and both in vivo and in vitro studies have shown evidence of anti-cancer effects.
We present a case of a patient with metastatic ovarian cancer who progressed through multiple lines
of chemotherapy but had a response and sustained stability in Ca-125 levels whilst taking graviola
tablets. Further clinical research is warranted to evaluate graviola’s role in cancer therapy.